GMP-compliant iPS cell lines show widespread plasticity in a new set of differentiation workflows for cell replacement and cancer immunotherapy.
Terheyden-Keighley D, Hühne M, Berger T, Hiller B, Martins S, Gamerschlag A, Sabour D, Meffert A, Kislat A, Slotta C, Hafezi F, Lichte J, Sudheer S, Tessmer K, Psathaki K, Ader M, Kogler G, Greber B.
Terheyden-Keighley D, et al. Among authors: sudheer s.
Stem Cells Transl Med. 2024 Sep 10;13(9):898-911. doi: 10.1093/stcltm/szae047.
Stem Cells Transl Med. 2024.
PMID: 39042522
Free PMC article.